Royal Philips is doing alright for itself, per earnings discussed during a recent call. This boost seems to be thanks to the multitude of acquisitions Philips…

DeepMind--a Google-owned AI company--has decided to suspend use of its Streams app.

Tandem Diabetes Care and TypeZero Technologies have entered into an agreement to bring together TypeZero’s artificial pancreas tech and Tandem’s t:slim Insulin…

Penumbra, one of the top devicemaker IPOs last year, unveiled its latest thrombectomy product to the U.S. market.

As expected, an FDA panel voted in favor of giving Dexcom’s G5 continuous glucose monitor a nonadjunctive indication that would allow it to be used in place of…

Materialise, which sells 3-D printing software and printing solutions to hospitals, has inked a deal with Johnson & Johnson’s DePuy Synthes to offer…

Former Acclarent CEO Bill Facteau has dealt with his fair share of legal drama after the Department of Justice (DOJ) accused him of improperly marketing one of…

ElectroCore is doing some shuffling. Frank Amato has been bumped up to the CEO position after having served as chief operating officer for the Merck-backed med…